Clinical trial

Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction

NCT07820410

Study summary

ClinicalTrials.gov

Atrial Shunt for the Treatment of Heart Failure With Reduced Ejection Fraction

Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2, PHASE3

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DEVICE · Unmapped registry intervention D-shant Atrial Shunt Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fraction Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-11-25

PhasePHASE2 / PHASE3

Conditions

Heart Failure With Reduced Ejection Fraction (HFrEF)unresolved

Interventions

D-shant Atrial ShuntDEVICE

Guideline-Directed Medical Therapy (GDMT) for heart failure with reduced ejection fractionDRUG

Sponsors & collaborators

Beijing Anzhen Hospitallead sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technologycollaborator

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07820410 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.